Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.410
+0.020 (1.44%)
At close: Nov 4, 2024, 4:00 PM
1.390
-0.020 (-1.43%)
After-hours: Nov 4, 2024, 7:34 PM EST
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$62,236
Profits / Employee
-$203,135
Market Cap
5.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mainz Biomed | 71 |
Biomerica | 64 |
Sunshine Biopharma | 44 |
Windtree Therapeutics | 20 |
Eterna Therapeutics | 8 |
GlucoTrack | 6 |
Hoth Therapeutics | 3 |
INBS News
- 4 days ago - Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - GlobeNewsWire
- 6 days ago - Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - GlobeNewsWire
- 19 days ago - Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Newsfile Corp
- 21 days ago - Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - GlobeNewsWire
- 26 days ago - Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution - GlobeNewsWire
- 4 weeks ago - GPS Marine Adopts Intelligent Bio Solutions' Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - GlobeNewsWire
- 5 weeks ago - UK's Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions' Fingerprint Drug Test to Enhance Workplace Safety - GlobeNewsWire